Study on cost-utility threshold based on the preference of population in Liaoning province

SUN Lihua; LI Shiqi; YE Ziping; Raela·Abduhilil; HUANG Jiaxin

doi:10.6039/j.issn.1001-0408.2023.12.12

您当前的位置：

首页 >

文章列表页 >

Study on cost-utility threshold based on the preference of population in Liaoning province

更新时间：2023-06-26

- Study on cost-utility threshold based on the preference of population in Liaoning province
- ZHONGGUO YAOFANG Vol. 34, Issue 12, Pages: 1473-1477(2023)
- 作者机构：
  
  沈阳药科大学工商管理学院，沈阳　110016
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.12.12
  CLC： R956
- Published：30 June 2023，
  
  Received：20 February 2023，
  
  Revised：26 March 2023，
扫描看全文
孙利华,李世琪,叶子平等.基于辽宁省人群偏好的成本-效用阈值研究 ^Δ[J].中国药房,2023,34(12):1473-1477.

SUN Lihua,LI Shiqi,YE Ziping,et al.Study on cost-utility threshold based on the preference of population in Liaoning province[J].ZHONGGUO YAOFANG,2023,34(12):1473-1477.
孙利华,李世琪,叶子平等.基于辽宁省人群偏好的成本-效用阈值研究 ^Δ[J].中国药房,2023,34(12):1473-1477. DOI： 10.6039/j.issn.1001-0408.2023.12.12.

SUN Lihua,LI Shiqi,YE Ziping,et al.Study on cost-utility threshold based on the preference of population in Liaoning province[J].ZHONGGUO YAOFANG,2023,34(12):1473-1477. DOI： 10.6039/j.issn.1001-0408.2023.12.12.

摘要

目的

通过意愿支付（WTP）调查法，研究基于辽宁省人群偏好的成本-效用阈值（WTP/Q），为相关决策提供依据和参考。

方法

采用问卷调查的方式，以配额抽样和滚雪球抽样相结合的抽样方法，对辽宁省一般人群进行电话访谈，收集调研数据并分析；使用Probit回归结合广义线性模型对影响WTP/Q的相关因素进行分析。

结果

共纳入一般人群755人，辽宁省人群的WTP/Q 为119 175元，对于提高生命质量的WTP/Q平均值为84 902元，而对于延长生存时期的WTP/Q平均值为188 005元。影响因素分析结果表明，年龄越大，人们购买医疗干预措施的概率越低；受教育程度越高，收入越高，WTP/Q值越大；同时，受访对象的身体感受如疼痛、抑郁也会影响WTP/Q结果；与改善生命质量的情境相比，延长生存时期情境的WTP/Q更高。

结论

基于WTP调查法估算的辽宁省WTP/Q约为同期辽宁省人均国内生产总值的2.07倍；延长生存时期情境的WTP/Q约是提高生命质量情境的2.21倍，在相关测算或决策中应对提高生命质量和延长生存时期的干预措施予以区别对待。

Abstract

OBJECTIVE

To study the cost-utility threshold （WTP/Q） based on the preference of the population in Liaoning province with willingness-to-pay（WTP） survey method， and to provide reference for decision-making.

METHODS

Using the method of questionnaire survey， quota sampling combined with snowball sampling were used to conduct telephone interviews with the general population in Liaoning province， collect data and analyze it. Probit regression combined with generalized linear model was used to analyze the relevant factors affecting WTP/Q.

RESULTS

A total of 755 general people were recruited. The WTP/Q of Liaoning population was 119 175 yuan，the average WTP/Q for improving the quality of life was 84 902 yuan， and the average WTP/Q for extending the survival period was 188 005 yuan. The analysis of influential factors showed that the older the age， the lower the probability of people purchasing medical interventions； the higher the education level and income， the greater the WTP/Q； at the same time， the physical feelings of the interviewee， such as pain and depression， could also affect the WTP/Q results； compared with the scenario of improving quality of life， the WTP/Q for the extended survival period was higher.

CONCLUSIONS

The WTP/Q of Liaoning province based on the WTP survey method is about 2.07 times of the per capita gross domestic product of Liaoning province in the same period. The WTP/Q for extending survival period is about 2.21 times that of improving the quality of life. Therefore， interventions to improve quality of life and to extend the survival period need to be treated differently， in measurement or decision-making.

关键词

药物经济学成本-效用阈值意愿支付调查法辽宁省

Keywords

cost-utility thresholdwillingness-to-pay methodLiaoning province

references

刘厚莲. 世界和中国人口老龄化发展态势[J]. 老龄科学研究，2021，9（12）：1-16.

陈燕，李琳，冉金昊. 积极老龄化视角下辽宁省养老服务“三支柱”体系建设研究[J]. 长沙民政职业技术学院学报，2022，29（3）：20-26.

马子华. 健康中国背景下基于“卫生费用核算体系2011”的辽宁省主要慢性疾病医疗费用研究[D]. 沈阳：中国医科大学，2021.

MASON H，BAKER R，DONALDSON C. Willingness to pay for a QALY：past，present and future[J]. Expert Rev Pharmacoecon Outcomes Res，2008，8（6）：575-582.

JrKING J T，TSEVAT J，LAVE J R，et al. Willingness to pay for a quality-adjusted life year：implications for so-cietal health care resource allocation[J]. Med Decis Ma-king，2005，25（6）：667-677.

ZHAO F L，YUE M，YANG H，et al. Willingness to pay per quality-adjusted life year：is one threshold enough for decision-making? Results from a study in patients with chronic prostatitis[J]. Med Care，2011，49（3）：267-272.

GAO L，XIA L，PAN S Q，et al. Health-related quality of life and willingness to pay per quality-adjusted life-year threshold： a study in patients with epilepsy in China[J]. Value Health Reg Issues，2015，6：89-97.

YE Z P，MA J，LIU F Y，et al. A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population[J]. Expert Rev Pharmacoecon Outcomes Res，2022，22（1）：53-61.

LINDSEY G. Market models，protest bids，and outliers in contingent valuation[J]. J Water Res Plan Man，1994，120（1）：121-129.

BLEICHRODT H，PINTO J L. A parameter-free elicitation of the probability weighting function in medical decision analysis[J]. Manag Sci，2000，46（11）：1485-1496.

叶子平. 基于需求角度的我国成本-效用阈值研究[D]. 沈阳：沈阳药科大学，2021.

CAI D，SHI S，JIANG S，et al. Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life[J]. Eur J Health Econ，2022，23（4）：607-615.

RYEN L，SVENSSON M. The willingness to pay for a quality adjusted life year：a review of the empirical literature[J]. Health Econ，2015，24（10）：1289-1301.

PENNINGTON M，BAKER R，BROUWER W，et al. Comparing WTP values of different types of QALY gain elicited from the general public[J]. Health Econ，2015，24（3）：280-293.

AHLERT M，BREYER F，SCHWETTMANN L. How you ask is what you get：framing effects in willingness-to-pay for a QALY[J]. Soc Sci Med，2016，150：40-48.

OLSEN J A，DONALDSON C. Helicopters，hearts and hips：using willingness to pay to set priorities for public sector health care programmes[J]. Soc Sci Med，1998，46（1）：1-12.

LIM Y W，SHAFIE A A，CHUA G N，et al. Determination of cost-effectiveness threshold for health care interventions in Malaysia[J]. Value Health，2017，20（8）：1131-1138.

LANKARANI K B，GHAHRAMANI S，MORADI N，et al. Willingness-to-pay for one quality-adjusted life-year：a population-based study from Iran[J]. Appl Health Econ Health Policy，2018，16（6）：837-846.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

辽宁省国家基本药物制度实施现状及其保障措施研究

Related Author

王迎王淑玲

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰